[1] Kalafateli M, Triantos C, Tsochatzis E, et al.Adipokines levels are associated with the severity of liver disease in patients with alcoholic cirrhosis.World J Gastroenterol,2015,21:3020-3029. [2] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会. 原发性胆汁性肝硬化(又名原发性胆汁性胆管炎)诊断和治疗共识(2015).临床肝胆病杂志,2015,31:1980-1988. [3] Floreani AI, Variola A, Niro G,et al.Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis. Am J Gastroenterol, 2008, 103:1959-1965. [4] 王立志,孙文锦,汪燕,等.慢加急性乙型肝炎肝衰竭患者血浆脂联素水平的变化及其临床意义.实用肝脏病杂志,2014,17:133-135. [5] 曹伟 何显 赵彩彦.乙型肝炎病毒相关肝功能衰竭患者肝组织脂联素及其受体2的表达.中华传染病杂志,2013, 31:231-235. [6] Tacke F, Wustefeld T, Horn R, et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol, 2005, 42:666-673. [7] Honsawek S, Chayanupatkul M, Chongsrisawat V, et al.Serum adiponectin and transient elastography as non-invasive markers for postoperative biliary atresia.BMC Gastroenterol, 2011,11: 16. [8] Kong B, Wang L, Chiang JY,et al.Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice.Hepatology, 2012,56:1034-1043. [9] Trivedi PJ, Hirschfield GM, Gershwin ME.Obeticholic acid for the treatment of primary biliary cirrhosis.Expert Rev Clin Pharmacol, 2016,9:13-26. [10] 辛小敏,钟慕晓,张珊珊,等.胆汁酸核受体激动剂对脂联素及其受体的影响.南方医科大学学报,2014,34:109-112. |